Thrilled to share that I have been awarded the Australian and New Zealand Society for Immunology (ASI) Breakthrough Immunology Award for exciting research into flavivirus encephalitis with @katherinekedz.bsky.social @thedohertyinst.bsky.social www.linkedin.com/posts/the-pe...

Why do some people get seriously ill while others don't? Our new study in @pnas.org investigated how a population of memory T cells influence #COVID severity Read the paper: go.unimelb.edu.au/4zkp Or our article here: go.unimelb.edu.au/2zkp @katherinekedz.bsky.social @thedohertyinst.bsky.social

Read the study in full: doi.org/10.1186/s128... @hepbvoicesau.bsky.social @hepatitisaustralia.bsky.social @genevieveemart1.bsky.social @thedohertyinst.bsky.social

NEW STUDY | Menzies’ researchers have led the largest-ever study of people living with a unique strain of chronic hepatitis B (C4 hep B), uncovering significant impacts on liver health. Learn more about these findings and the work of the Hep B PAST Plus program: www.menzies.edu.au/page/News_an...

Thrilled to share our new research led by Jane Davies @menziesresearch.bsky.social on First Nations people in the NT living with chronic hepatitis B. An important study that could inform better care: doi.org/10.1186/s128... #idsky #MedSky #HepSky #LiverSky

Excited to have contributed to the updated version of the Tropical Health Orientation Manual which has just been published by @menziesresearch.bsky.social 🐊🧫😷 #idsky

particularly acute kidney injury, bone marrow suppression, and severe cutaneous reactions, affecting over 50% of patients exposed. Notably, 44% required cessation or dose reduction due to toxicity www.sciencedirect.com/science/arti... www.sciencedirect.com/science/arti... @idsainfo.bsky.social

The wet season has arrived! ⛈️ Sharing our two new papers on clinical aspects of melioidosis 🧫 in the Top End of Australia 🐊🇦🇺 — work done with Prof Bart Currie and Prof Jane Davies at Menzies School of Health Research #IDSky